RPS2P39

Across TCGA pan-cancer cohorts, RPS2P39 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RPS2P39 data layer.

The strongest signal is observed in thymoma (THYM), where higher RPS2P39 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS2P39 expression acts as an unfavorable survival marker, although some lineages such as LAML and COAD show a favorable association.

THYM, BRCA, and LUAD are the cancer types where RPS2P39 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	III,IV	0.103	0.944	<.001	69	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	36	view →
LUAD	OS	Tertile	III,IV	0.223	0.677	.006	36	view →
CESC	DFS	Tertile	III,IV	0.190	0.727	.006	36	view →
ACC	DFS	Tertile	All	0.068	0.667	.005	36	view →
PCPG	DFS	Tertile	All	0.298	0.817	<.001	27	view →
SKCM	OS	Tertile	II,III,IV	0.174	0.418	.006	24	view →
THCA	DFS	Tertile	II,III,IV	0.180	0.793	.008	24	view →
LAML	DFS	Median	All	0.646	0.244	<.001	24	view →
COAD	OS	Tertile	III,IV	1.000	0.493	.025	15	view →
KIRP	DFS	Tertile	All	0.356	0.815	.017	15	view →
LGG	DFS	Tertile	All	0.198	0.408	.045	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RPS2P39–THYM (OS)

Open the THYM breakdown →